Skip navigation

Acquired platelet function defect

Acquired platelet function defects are conditions that prevent clotting elements in the blood called platelets from working as they should. The term "acquired" means these conditions are not present at birth.

Causes

With platelet disorders can affect the number of platelets, how well they function, or both. Any platelet disorder affects normal blood clotting.

Disorders that can cause problems in platelet function include:

Other causes include:

Symptoms

Exams and Tests

Treatment

Treatment is aimed at the cause of the problem.

  • Bone marrow disorders are treated with platelet transfusions or removing platelets from the blood (platelet pheresis). Chemotherapy is can used to treat an underlying condition that is causing the problem.
  • Platelet function defects caused by kidney failure are treated with dialysis or a drug called desmopressin (ddAVP).
  • Platelet problems caused by a certain medicine are treated by stopping the drug.

Outlook (Prognosis)

Most of the time, treating the cause of the problem corrects the defect.

Possible Complications

  • Prolonged bleeding
  • Severe anemia

When to Contact a Medical Professional

Call your health care provider if:

  • You have bleeding and do not know the cause
  • Your symptoms get worse
  • Your symptoms do not improve after you are treated for an acquired platelet function defect

Prevention

Using medicines as directed  can reduce the risk of drug-related acquired platelet function defects. Treating other disorders may also reduce the risk. Some cases cannot be prevented.

Alternative Names

Acquired qualitative platelet disorders; Acquired disorders of platelet function

References

Diz-Kucukkaya R, Lopez JA, Acquired disorders of platelet function. In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz JI, eds. Hematology: Basic Principles and Practice. 6th ed. Philadelphia, PA: Saunders Elsevier; 2012:chap 132.

Ragni MV. Hemorrhagic Disorders: Coagulation Factor Deficiencies. In: Goldman L, Schafer AI, eds. Goldman's Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 177.

Update Date: 3/3/2013

Updated by: Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by A.D.A.M. Health Solutions, Ebix, Inc., Editorial Team: David Zieve, MD, MHA, Bethanne Black, Stephanie Slon, and Nissi Wang.

A.D.A.M Quality Logo

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2014, A.D.A.M., Inc. Duplication for commercial use must be authorized in writing by ADAM Health Solutions.

A.D.A.M Logo